Skip to main content
Erschienen in: Neuroradiology 5/2004

01.05.2004 | Diagnostic Neuroradiology

MR imaging and spectroscopy in Lhermitte-Duclos disease

verfasst von: S. Nagaraja, T. Powell, P. D. Griffiths, I. D. Wilkinson

Erschienen in: Neuroradiology | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

Lhermitte-Duclos disease is a rare abnormality occurring in the cerebellum with only 130 cases reported in the literature. There is debate as to whether this abnormality is a hamartoma, a malformation or a tumour. In this case report we discuss the spectroscopy findings from two patients presenting with this disease. The patients, one 40-year-old Caucasian woman with a 6-year history of headaches, unsteady gait and falls, deterioration in vision and another 28-year-old Caucasian man with a 1-year history of headaches and a previous history of a transient stroke, were found to have this lesion in the cerebellum. Proton spectroscopic data were obtained using a single-voxel PRESS technique (TE=135 ms, TR=1600 ms), from the region of the abnormality. The results were expressed as ratios under the three prominent resonances representing choline (Cho), creatine (Cr), and N-acetyl (NA) moieties. The metabolite ratios were compared to normative data. The two cases demonstrated reduced ratios in NA/Cho and NA/Cr in relation to the controls. The ratios of Cho/Cr appeared closer to the normal mean ratio. There were peaks attributable to lactate in both cases. The low NA/Cr and NA/Cho ratios could be due to the apparent lack of neuronal architecture and the presence of embryonic neural tissue, which does not express NA, indicating more favourably towards a ‘benign’ hamartoma rather than a tumour.
Literatur
1.
Zurück zum Zitat Ashley DG, Zee CS, Chandrasoma PT, Segall HD (1990) Lhermitte-Duclos disease: CT and MR findings. J Comput Assist Tomogr 14:984–987PubMed Ashley DG, Zee CS, Chandrasoma PT, Segall HD (1990) Lhermitte-Duclos disease: CT and MR findings. J Comput Assist Tomogr 14:984–987PubMed
2.
Zurück zum Zitat Klisch J, Juengling F, Spreer J, Koch D, Thiel T, Buchert M, Arnold S, Feuerhake F, Schumacher M (2001) Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 22:824–830PubMed Klisch J, Juengling F, Spreer J, Koch D, Thiel T, Buchert M, Arnold S, Feuerhake F, Schumacher M (2001) Lhermitte-Duclos disease: assessment with MR imaging, positron emission tomography, single-photon emission CT, and MR spectroscopy. AJNR Am J Neuroradiol 22:824–830PubMed
3.
Zurück zum Zitat Murray C, Shipman P, Khangure M, Chakera T, Robbins P, McAuliffe W, Davis S (2001) Lhermitte-Duclos disease associated with Cowden’s syndrome: case report and literature review. Australas Radiol 45:343–346CrossRefPubMed Murray C, Shipman P, Khangure M, Chakera T, Robbins P, McAuliffe W, Davis S (2001) Lhermitte-Duclos disease associated with Cowden’s syndrome: case report and literature review. Australas Radiol 45:343–346CrossRefPubMed
4.
Zurück zum Zitat Nowak DA, Trost HA, Porr A, Stolzle A, Lumenta CB (2001) Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 103:105–110CrossRefPubMed Nowak DA, Trost HA, Porr A, Stolzle A, Lumenta CB (2001) Lhermitte-Duclos disease (dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 103:105–110CrossRefPubMed
5.
Zurück zum Zitat Roski RA, Roessmann U, Spetzler RF, Kaufman B, Nulsen FE (1981) Clinical and pathological study of dysplastic gangliocytoma. Case report. J Neurosurg 55:318–321PubMed Roski RA, Roessmann U, Spetzler RF, Kaufman B, Nulsen FE (1981) Clinical and pathological study of dysplastic gangliocytoma. Case report. J Neurosurg 55:318–321PubMed
6.
Zurück zum Zitat Nowak DA, Trost HA (2002) Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 105:137–145CrossRefPubMed Nowak DA, Trost HA (2002) Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm? Acta Neurol Scand 105:137–145CrossRefPubMed
7.
Zurück zum Zitat Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116PubMed Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat Genet 13:114–116PubMed
8.
Zurück zum Zitat Albrecht S, Haber RM, Goodman JC, Duvic M (1992) Cowden syndrome and Lhermitte-Duclos disease. Cancer 70:869–876PubMed Albrecht S, Haber RM, Goodman JC, Duvic M (1992) Cowden syndrome and Lhermitte-Duclos disease. Cancer 70:869–876PubMed
9.
Zurück zum Zitat Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC (1991) Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 29:517–523PubMed Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC (1991) Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol 29:517–523PubMed
10.
11.
Zurück zum Zitat Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMed Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64–67PubMed
12.
Zurück zum Zitat Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW (1999) Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 82:290–293CrossRefPubMed Sutphen R, Diamond TM, Minton SE, Peacocke M, Tsou HC, Root AW (1999) Severe Lhermitte-Duclos disease with unique germline mutation of PTEN. Am J Med Genet 82:290–293CrossRefPubMed
13.
Zurück zum Zitat Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232CrossRefPubMed Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232CrossRefPubMed
14.
Zurück zum Zitat Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 16:1821–1833PubMed Wang Z, Sutton LN, Cnaan A, Haselgrove JC, Rorke LB, Zhao H, Bilaniuk LT, Zimmerman RA (1995) Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 16:1821–1833PubMed
15.
Zurück zum Zitat Wilken B, Helms G, Christen HJ, Behnke J, Frahm J, Hanefeld F (1996) Localized proton magnetic resonance spectroscopy of a cerebellar tumor in a two-year-old child. Childs Nerv Syst 12:626–629PubMed Wilken B, Helms G, Christen HJ, Behnke J, Frahm J, Hanefeld F (1996) Localized proton magnetic resonance spectroscopy of a cerebellar tumor in a two-year-old child. Childs Nerv Syst 12:626–629PubMed
16.
Zurück zum Zitat Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF3, Johnston KW, Robinson JS, Jr., Papadakis N (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83–94CrossRefPubMed Fountas KN, Kapsalaki EZ, Gotsis SD, Kapsalakis JZ, Smisson HF3, Johnston KW, Robinson JS, Jr., Papadakis N (2000) In vivo proton magnetic resonance spectroscopy of brain tumors. Stereotact Funct Neurosurg 74:83–94CrossRefPubMed
17.
Zurück zum Zitat Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342:163–166CrossRefPubMed Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, Sartor K (2003) Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy. Neurosci Lett 342:163–166CrossRefPubMed
18.
Zurück zum Zitat Vuori K, Kankaanranta L, Hakkinen AM, Gaily E, Valanne L, Granstrom ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230:703–708PubMed Vuori K, Kankaanranta L, Hakkinen AM, Gaily E, Valanne L, Granstrom ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230:703–708PubMed
Metadaten
Titel
MR imaging and spectroscopy in Lhermitte-Duclos disease
verfasst von
S. Nagaraja
T. Powell
P. D. Griffiths
I. D. Wilkinson
Publikationsdatum
01.05.2004
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 5/2004
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1201-7

Weitere Artikel der Ausgabe 5/2004

Neuroradiology 5/2004 Zur Ausgabe

Announcements

May 2004

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.